Last reviewed · How we verify

essential oils, mouthwash

University of Santiago de Compostela · FDA-approved active Small molecule Quality 5/100

Essential oils, marketed as a mouthwash by the University of Santiago de Compostela, hold a niche position in the oral care market. The key composition patent, set to expire in 2028, provides a significant barrier to entry for potential competitors. However, the lack of a clear primary indication and revenue data poses a strategic risk, potentially limiting market expansion and investment.

At a glance

Generic nameessential oils, mouthwash
Also known asListerine, Listerine Mentol, essential oil
SponsorUniversity of Santiago de Compostela
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: